Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Remission Induction in a Phase 1 Study of a Bispecific Single Chain Immunotoxin Targeting CD22 and CD19 (DT2219) for Refractory B-Cell Malignancies

Veronika Bachanova, MD, Arthur Frankel, Qing Cao, MS, Dixie Lewis, Michael Verneris, MD, Aleksandr Lazaryan, MD PhD MPH, Linda J. Burns, MD, Daniel Vallera, PhD

Blood (2014) 124 (21): 3098.

https://doi.org/10.1182/blood.V124.21.3098.3098

Published: 2014

Journal Articles

The Effect of Transplant Center Characteristics On Survival After Pediatric Hematopoietic Cell Transplantation

Michael J Eckrich, MD, MPH, Jennifer Le-Rademacher, PhD, J. Douglas Rizzo, MD, MS, K. Scott Baker, MD, MS, Deepika Bhatla, MD, David K. Buchbinder, M.D., M.S.H.S., Kenneth R. Cooke, MD, Reggie Duerst, MD, Andrew Gilman, MD, Haydar Frangoul, MD, Neena Kapoor, MD, Nancy A. Kernan, MD, Michael Verneris, MD, Mary Eapen, MBBS

Blood (2012) 120 (21): 762.

https://doi.org/10.1182/blood.V120.21.762.762

Published: 2012

Journal Articles

In Vitro Generation of NK22 Cells From Hematopoietic Stem Cells

Qin Tang, MS, Ahn Yong-Oon, Ph.D., Peter Southern, Ph.D., Bruce R. Blazar, MD, Jeffrey S Milller, MD, Michael Verneris, MD

Blood (2010) 116 (21): 108.

https://doi.org/10.1182/blood.V116.21.108.108

Published: 2010

Journal Articles

NK Education: Disassociation Between Recovery of Cytoxicity and Cytokine Production In NK Cells After Allogeneic Transplantation.

Bree Foley, PhD, Sarah Cooley, MD, Julie Curtsinger, PhD, Michael Verneris, MD, Daniel J. Weisdorf, MD, Jeffrey S. Miller, MD

Blood (2010) 116 (21): 1462.

https://doi.org/10.1182/blood.V116.21.1462.1462

Published: 2010

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation Overcomes the Adverse Prognostic Impact of CD20 Expression In Both Adult and Pediatric Acute Lymphoblastic Leukemia.

Veronika Bachanova, Karamjeet Sandhu, MD, Daniel J. Weisdorf, MD, Michael Verneris, MD, Michael J Burke, MD, Qing Cao, MS

Blood (2010) 116 (21): 1681.

https://doi.org/10.1182/blood.V116.21.1681.1681

Published: 2010

Journal Articles

Tim-3, a Novel Immune Receptor, Is Constitutively Expressed on Human Natural Killer Cells and Functions as An Activating Coreceptor

Michelle Gleason, Todd Lenvik, Valarie McCullar, Sarah Cooley, MD, Michael Verneris, MD, Toshiro Niki, Mitsuomi Hirashima, Bruce R. Blazar, MD, Jeffrey S. Miller, MD

Blood (2010) 116 (21): 106.

https://doi.org/10.1182/blood.V116.21.106.106

Published: 2010

Journal Articles

Kinetics of Chimerism and Unit Predominance After Double Umbilical Cord Blood Transplantation

Pablo A. Ramirez, MD, John E. Wagner, MD, Todd Defor, MS, Bruce R. Blazar, MD, Michael Verneris, MD, Jeffrey S. Miller, MD, Daniel J. Weisdorf, MD, Phillip McGlave, MD, Claudio Brunstein, MD

Blood (2010) 116 (21): 225.

https://doi.org/10.1182/blood.V116.21.225.225

Published: 2010

Journal Articles

Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) for Treatment of Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (ALL).

Michael Burke, MD, Barb Trotz, BA, BSN, MSN, Qing Cao, MS, Brenda Weigel, MSc, MD, Ashish Kumar, MBBS, PhD, Angela Smith, MD, MS, Michael Verneris, MD

Blood (2009) 114 (22): 3377.

https://doi.org/10.1182/blood.V114.22.3377.3377

Published: 2009

Journal Articles

Successful Haploidentical Hematopoietic Cell Engraftment Using a Non-Myeloablative Preparative Regimen Including Natural Killer (NK) Cells

Sarah Cooley, Purvi Gada, David McKenna, Valarie McCullar, Susan Fautsch, Michael Verneris, Bruce R Blazar, Linda J Burns, Philip B McGlave, MD, Daniel J. Weisdorf, Jeffrey S Miller

Blood (2008) 112 (11): 827.

https://doi.org/10.1182/blood.V112.11.827.827

Published: 2008

Journal Articles

Blocking Inhibitory KIR Is Insufficient for Optimal Killing of AML and ALL Targets: Additional Requirements for NKG2A and LIR-1 Blockade

Robert Godal, Michelle Gleason, Valarie McCullar, Sarah Cooley, MD, Veronika Bachanova, Michael Verneris, MD, Philip McGlave, MD, Jeffrey S. Miller, MD

Blood (2008) 112 (11): 2906.

https://doi.org/10.1182/blood.V112.11.2906.2906

Published: 2008

Journal Articles

Identification of a Myeloid Pathway of NK Cell Development and a Myeloid- NK Cell Precursor

Bartosz Grzywacz, MD, Nandini Kataria, BS, Bruce R. Blazar, MD, Jeffrey S. Miller, MD, Michael Verneris, MD

Blood (2008) 112 (11): 103.

https://doi.org/10.1182/blood.V112.11.103.103

Published: 2008

Journal Articles

Negative Effect of KIR Alloreactivity in Recipients of Umbilical Cord Blood Transplantation Depends on Transplantation Conditioning Intensity

Claudio Brunstein, MD, PhD, John E. Wagner, MD, Daniel Weisdorf, MD, Sarah Cooley, MD, Harriet Noreen, Juliet Barker, MBBS, Todd DeFor, Michael Verneris, MD, Philip B. McGlave, Bruce R. Blazar, MD, Jeffrey S. Miller, MD

Blood (2008) 112 (11): 152.

https://doi.org/10.1182/blood.V112.11.152.152

Published: 2008

Journal Articles

Prolonged Survival in Adults with Acute Lymphoblastic Leukemia (ALL) Following Reduced Intensity Conditioning and Allogeneic Transplantation

Veronika Bachanova, Daniel J. Weisdorf, Claudio Brunstein, MD, PhD, John Wagner, MD, Michael Verneris, MD

Blood (2008) 112 (11): 4415.

https://doi.org/10.1182/blood.V112.11.4415.4415

Published: 2008

Journal Articles

Killer Immunoglobulin Receptor (KIR) Negative NK Cells Exhibit Potent Alloreactivity Against Primary Leukemia Targets When Interrupting MHC Class I Interactions through NKG2A Blockade.

Robert Godal, MD, Michelle Gleason, Valarie McCullar, Sarah Cooley, MD, Michael Verneris, MD, Philip McGlave, MD, Jeffrey S. Miller, MD

Blood (2007) 110 (11): 2862.

https://doi.org/10.1182/blood.V110.11.2862.2862

Published: 2007

Journal Articles

Promising Progression Free and Overall Survival Using a Novel (CY/FLU/TBI) Reduced-Intensity Conditioning (RIC) Regimen for Allogeneic Sibling Stem Cell Transplantation (SCT).

Marcie Tomblyn, MD, MS, Jeffrey S. Miller, MD, Linda J. Burns, MD, Bruce R. Blazar, MD, PhD, Mukta Arora, MD, MS, Xianghua Luo, PhD, Todd Defor, MS, Claudio Brunstein, MD, PhD, Kathryn Dusenbery, MD, Margaret L. MacMillan, MD, Michael Verneris, MD, PhD, John Wagner, MD, Daniel J. Weisdorf, MD

Blood (2006) 108 (11): 2999.

https://doi.org/10.1182/blood.V108.11.2999.2999

Published: 2006

Journal Articles

Fetal microchimerism—what our children leave behind

Michael Verneris

Blood (2003) 102 (10): 3465–3466.

https://doi.org/10.1182/blood-2003-09-3027

Published: 2003

NARROW

Remission Induction in a Phase 1 Study of a Bispecific Single Chain Immunotoxin Targeting CD22 and CD19 (DT2219) for Refractory B-Cell Malignancies

The Effect of Transplant Center Characteristics On Survival After Pediatric Hematopoietic Cell Transplantation

In Vitro Generation of NK22 Cells From Hematopoietic Stem Cells

NK Education: Disassociation Between Recovery of Cytoxicity and Cytokine Production In NK Cells After Allogeneic Transplantation.

Allogeneic Hematopoietic Stem Cell Transplantation Overcomes the Adverse Prognostic Impact of CD20 Expression In Both Adult and Pediatric Acute Lymphoblastic Leukemia.

Tim-3, a Novel Immune Receptor, Is Constitutively Expressed on Human Natural Killer Cells and Functions as An Activating Coreceptor

Kinetics of Chimerism and Unit Predominance After Double Umbilical Cord Blood Transplantation

Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) for Treatment of Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (ALL).

Successful Haploidentical Hematopoietic Cell Engraftment Using a Non-Myeloablative Preparative Regimen Including Natural Killer (NK) Cells

Blocking Inhibitory KIR Is Insufficient for Optimal Killing of AML and ALL Targets: Additional Requirements for NKG2A and LIR-1 Blockade

Identification of a Myeloid Pathway of NK Cell Development and a Myeloid- NK Cell Precursor

Negative Effect of KIR Alloreactivity in Recipients of Umbilical Cord Blood Transplantation Depends on Transplantation Conditioning Intensity

Prolonged Survival in Adults with Acute Lymphoblastic Leukemia (ALL) Following Reduced Intensity Conditioning and Allogeneic Transplantation

Killer Immunoglobulin Receptor (KIR) Negative NK Cells Exhibit Potent Alloreactivity Against Primary Leukemia Targets When Interrupting MHC Class I Interactions through NKG2A Blockade.

Promising Progression Free and Overall Survival Using a Novel (CY/FLU/TBI) Reduced-Intensity Conditioning (RIC) Regimen for Allogeneic Sibling Stem Cell Transplantation (SCT).

Fetal microchimerism—what our children leave behind

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only